Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells

Molecular Immunology

Volumn 48, Issue 1-3, 2010, Pages 109-118

  Simone, Rita ^a   Barbarat, Bernadette ^b   Rabellino, Andrea ^a,c   Icardi, Giancarlo ^a   Bagnasco, Marcello ^d   Pesce, Giampaola ^d   Olive, Daniel ^b   Saverino, Daniele ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b INSTITUT PAOLI CALMETTES   (France)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

B7 family; BT3; Dendritic cells; Monocytes; Toll like receptors

Indexed keywords

B7 ANTIGEN; BT3 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 8; LYMPHOCYTE ANTIGEN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL SURVIVAL; CROSS LINKING; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOREGULATION; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD80; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 78649514107     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.09.005     Document Type: Article

References (44)

1. Arnett H.A., Escobar S.S., Gonzalez-Suarez E., Budelsky A.L., Steffen L.A., Boiani N., Zhang M., Siu G., Brewer A.W., Viney J.L. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 2007, 178:1523-1533.
2. Bensussan A., Olive D. T-cell: section report. Cell. Immunol. 2005, 236:3-5.
3. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002, 20:29-53.
4. Chambers C.A., Kuhns M.S., Egen J.G., Allison J.P. CTLA-4-mediated inhibition in regulation of T cells responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 2001, 19:565-594.
5. Chapoval A.I., Ni J., Lau J.S., Wilcox R.A., Flies D.B., Liu D., Dong H., Sica G.L., Zhu G., Tamada K., Chen L. B7 H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat. Immunol. 2001, 2:269-274.
6. Compte E., Pontarotti P., Collette Y., Lopez M., Olive D. Characterization of BT3 molecules belong to the B7 family expressed on immune cells. Eur. J. Immunol. 2004, 34:2089-2099.
7. Coyle A.J., Gutierrez-Ramos J.C. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2001, 2:203-209.
8. Dong H., Zhu G., Tamada K., Chen L. B7 H1, a third member of B7 family, co-stimulates T cell proliferation and interleukin-10 secretion. Nat. Med. 1999, 5:1365-1369.
9. Durum S.K., Schmidt J.A., Oppenheim J.J. Interleukin 1: an immunological perspective. Annu. Rev. Immunol. 1985, 3:263-287.
10. Eisenberg S.P., Evans R.J., Arend W.P., Verderber E., Brewer M.T., Hannun C.H., Thompson R.C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990, 343:341-346.
11. Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L., Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R., Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000, 192:1027-1034.
12. Fulton S.A., Johnsen J.M., Wolf S.F., Sieburth D.S., Boom W.H. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect. Immun. 1996, 64:2523-2531.
13. Grob P.M., David E., Warren T.C., De Leon R.P., Farina P.R., Homon C.A. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J. Biol. Chem. 1990, 265:8311-8316.
14. Henry J., Mather I.H., McDermott M.F., Pontarotti P. B30 2-like domain proteins: update and new insights into a rapidly expanding family of proteins. Mol. Biol. Evol. 1998, 15:1696-1705.
15. Henry J., Miller M., Pontarotti P. Structure and evolution of the extended B7 family. Immunol. Today 1999, 20:285-288.
16. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T cell co-stimulator structurally and functionally related to CD28. Nature 1999, 397:263-266.
17. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. The B7 and CD28 receptor families. Immunol. Today 1994, 15:321-331.
18. Kaufman J., Salomonsen J. B-G: we know what it is, but what does it do?. Immunol. Today 1992, 13:1-3.
19. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., Iwai Y., Long A.J., Brown J.A., Nunes R., Greenfield E.A., Bourque K., Boussiotis V.A., Carter L.L., Carreno B.M., Malenkovich N., Nishimura H., Okazaki T., Honjo T., Sharpe A.H., Freeman G.J. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001, 2:261-274.
20. Ledbetter J.A., Imboden J.B., Schieven G.L., Grosmaire L.S., Rabinovitch P.S., Lindsten T., Thompson C.B., June C.H. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 1990, 75:1531-1539.
21. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 of T cell co-stimulation. Annu. Rev. Immnuol. 1996, 14:233-258.
22. Linsley P.S., Greene J.L., Tane P., Bradshaw J., Ledbetter J.A., Anasetti C., Damle N.K. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 1992, 176:1595-15604.
23. Linsley P.S., Ledbetter J.A. The role of the CD 28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993, 11:191-212.
24. Liu Y., Linsley P.S. Costimulation of T-cell growth. Curr. Opin. Immunol. 1992, 4:265-270.
25. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., Trinchieri G. The interleukin-12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 1996, 183:147-157.
26. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1:135-145.
27. Nurieva R., Thomas S., Nguyen T., Martin-Orozco N., Wang Y., Kaja M.K., Yu X.Z., Dong C. T-cell tolerance or function is determined by combinatorial costimulatory signals. Embo J. 2006, 25:2623-2633.
28. Price P., Santoso F., Mastaglia M., Garlepp C., Kok C., Allcock R., Laing N. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. Tissue Antigens 2004, 64:575-580.
29. Rhodes D.A., Stammers M., Malcherek G., Beck S., Trowsdale J. The cluster of BTN genes in the extended major histocompatibility complex. Genomics 2001, 71:351-362.
30. Ruddy D.A., Kronmal G.S., Lee V.K., Mintier G.A., Quintana L., Domingo R., Meyer N.C., Irrinki A., McClelland E.E., Fullan A., Mapa F.A., Moore T., Thomas W., Loeb D.B., Harmon C., Tsuchihashi Z., Wolff R.K., Schatzman R.C., Feder J.N. A 1 1-Mb transcript map of the hereditary hemochromatosis locus. Genome Res. 1997, 7:441-456.
31. Rybicki B.A., Walewski J.L., Maliarik M.J., Kian H., Iannuzzi M.C. The BTNL2 gene and sarcoidosis susceptibility in African Americans andWhites. Am. J. Hum. Genet. 2005, 77:491-499.
32. Salmaso C., Olive D., Pesce G., Bagnasco M. Costimulatory molecules and auoimmune thyroid diseases. Autoimmunity 2002, 35:159-167.
33. Saverino D., Tenca C., Zarcone D., Merlo A., Megiovanni A.M., Valle M.T., Manca F., Grossi C.E., Ciccone E. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion. J. Immunol. 1998, 162:651-658.
34. Sun M., Richards S., Prasad D.V., Mai X.M., Rudensky A., Dong C. Characterization of mouse and human B7-H3 genes. J. Immunol. 2002, 168:6294-6297.
35. Takeda K., Akira S. Toll receptors and pathogen resistance. Cell Microbiol. 2003, 5:143-153.
36. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., Tsuchiya H. B7 DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 2001, 193:839-846.
37. Valentonyte R., Hampe J., Huse K., Rosenstiel P., Albrecht M., Stenzel A., Nagy M., Gaede K.I., Franke A., Haesler R., Koch A., Lengauer T., Seegert D., Reiling N., Ehlers S., Schwinger E., Platzer M., Krawczak M., Müller-Quernheim J., Schürmann M., Schreiber S. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 2005, 37:357-364.
38. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994, 1:405-413.
39. Walunas T.L., Bluestone J.A. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J. Immunol. 1998, 160:3855-3860.
40. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., Mak T.W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270:985-988.
41. Waterhouse P., Marengere L.E.M., Mittrucker H.-W., Mak T.W. CTLA-4, a negative regulator of T-lymphocyte activation. Immnunol. Rev. 1996, 153:183-207.
42. Williams A.F., Barclay A.N. The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol. 1988, 6:381-405.
43. Wolf S.F., Sieburth D., Sypek J. Interleukin-12: a key modulator of immune function. Stem Cells 1994, 12:154-168.
44. Yi-qun Z., Lorrè K., de Boer M., Ceuppens J.L. B7 blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells. J. Immunol. 1997, 158:4734-4740.